Methyl-hydroxylamine as an efficacious antibacterial agent that targets the ribonucleotide reductase enzyme

PloS One
Esther JuliánEduard Torrents

Abstract

The emergence of multidrug-resistant bacteria has encouraged vigorous efforts to develop antimicrobial agents with new mechanisms of action. Ribonucleotide reductase (RNR) is a key enzyme in DNA replication that acts by converting ribonucleotides into the corresponding deoxyribonucleotides, which are the building blocks of DNA replication and repair. RNR has been extensively studied as an ideal target for DNA inhibition, and several drugs that are already available on the market are used for anticancer and antiviral activity. However, the high toxicity of these current drugs to eukaryotic cells does not permit their use as antibacterial agents. Here, we present a radical scavenger compound that inhibited bacterial RNR, and the compound's activity as an antibacterial agent together with its toxicity in eukaryotic cells were evaluated. First, the efficacy of N-methyl-hydroxylamine (M-HA) in inhibiting the growth of different Gram-positive and Gram-negative bacteria was demonstrated, and no effect on eukaryotic cells was observed. M-HA showed remarkable efficacy against Mycobacterium bovis BCG and Pseudomonas aeruginosa. Thus, given the M-HA activity against these two bacteria, our results showed that M-HA has intracellular antimy...Continue Reading

References

Oct 30, 1992·Biochemical and Biophysical Research Communications·G LassmannA Gräslund
Apr 9, 1999·The Journal of Clinical Investigation·J WangZ Xing
Jul 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·A TrifilieffC Bertrand
Jun 28, 2001·Clinical and Diagnostic Laboratory Immunology·A Weinberg
Feb 14, 2002·Biochemical Pharmacology·Marion Man-Ying Chan
Dec 3, 2005·Proceedings of the National Academy of Sciences of the United States of America·Eduard TorrentsBritt-Marie Sjöberg
May 10, 2006·Cellular Microbiology·Elsa AnesGareth Griffiths
Jun 8, 2006·Annual Review of Biochemistry·Pär Nordlund, Peter Reichard
Jul 11, 2006·The Journal of Biological Chemistry·Eduard TorrentsBritt-Marie Sjöberg
Jul 18, 2006·Journal of Neuroimmunology·Pierluigi NavarraPaolo Preziosi
Aug 22, 2006·Current Cancer Drug Targets·J ShaoY Yen
Apr 24, 2007·The Journal of Antimicrobial Chemotherapy·John J DochertyTristan D Booth
Aug 19, 2007·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Srdjan StepanovićFilip Ruzicka
Nov 8, 2007·Cellular Microbiology·Luisa JordaoElsa Anes
Jan 4, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brad SpellbergUNKNOWN Infectious Diseases Society of America
Jan 29, 2008·Recent Patents on Anti-cancer Drug Discovery·Nuno M F S A CerqueiraMaria J Ramos
Jul 2, 2008·Infection and Immunity·Joerg OverhageRobert E W Hancock
Sep 20, 2008·Science·David J Payne
Nov 18, 2008·Biochemistry·A Quamrul HassanJoAnne Stubbe
Apr 8, 2009·Cancer Chemotherapy and Pharmacology·Nina Saban, Maro Bujak
Dec 17, 2009·Molecular Cell·Bryan W DaviesGraham C Walker
Dec 15, 2010·BMC Evolutionary Biology·Daniel LundinAnthony M Poole
Apr 5, 2011·Annual Review of Biochemistry·Joseph A Cotruvo, Joanne Stubbe
May 4, 2011·Current Protocols in Microbiology·Tim Tolker-Nielsen, Claus Sternberg
Sep 29, 2011·Archives of Biochemistry and Biophysics·Jinghui Luo, Astrid Gräslund
Nov 5, 2011·Critical Reviews in Biochemistry and Molecular Biology·Anders HoferBritt-Marie Sjöberg
Jul 6, 2012·Clinical Microbiology Reviews·Pranita D TammaLisa L Maragakis
Feb 2, 2013·Current Topics in Medicinal Chemistry·Arijit Basu, Barij Nayan Sinha
Sep 17, 2013·Mini Reviews in Medicinal Chemistry·Narayana S H N MoorthyPedro A Fernandes
Mar 4, 2014·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Marta HammerstadK Kristoffer Andersson

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
enzyme-linked immunosorbent assays
confocal microscopy

Software Mentioned

Graph Pad Prism
SPSS
SigmaStat
ImageJ
COMSTAT

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2021 Meta ULC. All rights reserved